Cleared Traditional

MAGNETOM Free.Max (K251822) - FDA 510(k) Clearance

Also marketed or referenced as:
MAGNETOM Free.Star

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2025
Decision
160d
Days
Class 2
Risk

K251822 is an FDA 510(k) clearance for the MAGNETOM Free.Max. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Siemens Shenzhen Magnetic Resonance , Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on November 20, 2025 after a review of 160 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Shenzhen Magnetic Resonance , Ltd. devices

Submission Details

510(k) Number K251822 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2025
Decision Date November 20, 2025
Days to Decision 160 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 107d · This submission: 160d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Siemens Medical Solutions USA, Inc.
Alina Goodman

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 485
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K251822.
AIR Recon DL
K252379 · Ge Medical Systems, LLC · Dec 2025
MAGNETOM Sola
K252838 · Siemens Healthcare GmbH · Dec 2025
Swoop® Portable MR Imaging® System
K253489 · Hyperfine, Inc. · Dec 2025
uMR 680
K252371 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025
ECHELON Synergy
K251386 · Fujifilm Corporation · Sep 2025
SIGNA™ Sprint
K251399 · Ge Medical Systems, LLC · Sep 2025